XML 21 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock [Member]
Accumulated Deficit [Member]
Total
Balances, beginning of period at Dec. 31, 2022 $ 474,847 $ (464,818) $ 10,029
Balances, beginning of period (in shares) at Dec. 31, 2022 118,480,878    
Shares issued, net of offering costs $ 453   453
Shares issued, net of offering costs (in shares) 834,146    
Shares issued (RSUs vested, net of shares withheld) $ (142)   (142)
Shares issued (RSUs vested, net of shares withheld) (in shares) 412,548    
Stock-based compensation $ 179   179
Net loss   (1,971) (1,971)
Balances, end of period at Mar. 31, 2023 $ 475,337 (466,789) 8,548
Balances, end of period (in shares) at Mar. 31, 2023 119,727,572    
Balances, beginning of period at Dec. 31, 2023 $ 476,354 (471,403) 4,951
Balances, beginning of period (in shares) at Dec. 31, 2023 121,088,494    
Shares issued, net of offering costs $ 53   53
Shares issued, net of offering costs (in shares) 100,000    
Shares issued (RSUs vested, net of shares withheld) $ (85)   (85)
Shares issued (RSUs vested, net of shares withheld) (in shares) 445,551    
Stock-based compensation $ 291   291
Net loss   (1,073) (1,073)
Balances, end of period at Mar. 31, 2024 $ 476,613 $ (472,476) $ 4,137
Balances, end of period (in shares) at Mar. 31, 2024 121,634,045